Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Torsemide ingredients?Daridorexant synthesis patent example iupac?Valsartan 320 mg cost?How much does suboxone go for on the street?How much is valtoco without insurance?
See the DrugPatentWatch profile for acarbose
When does the patent for acarbose expire? The patent covering acarbose, specifically its biosynthesis, is set to expire in June 2025 [1]. This expiry date pertains to the patent held by Bayer [1]. What is acarbose used for? Acarbose is a medication used to treat type 2 diabetes [2]. It functions by slowing down the digestion of carbohydrates [2]. This helps to reduce the blood sugar spikes that can occur after meals [2]. How does acarbose biosynthesis work? Acarbose is produced through a fermentation process using the microorganism Actinoplanes utahensis [1]. The biosynthesis pathway involves a series of enzymatic steps that convert precursor molecules into the final acarbose compound [1]. Patents related to acarbose biosynthesis often focus on specific strains of the microorganism or optimized fermentation conditions to improve yield and purity [1]. Who manufactures acarbose? While Bayer originally developed and patented acarbose, other pharmaceutical companies also manufacture and market generic versions of the drug [3]. The patent expiry will likely lead to increased competition from generic manufacturers. What is the impact of patent expiry on acarbose pricing? Patent expiry typically allows for the introduction of generic versions of a drug, which can significantly lower prices due to increased competition [3]. This makes the medication more accessible to patients and healthcare systems [3]. What are the challenges to acarbose patents? Pharmaceutical patents, including those for acarbose biosynthesis, can face challenges from other companies seeking to market generic versions [4]. These challenges often involve arguing that the patent is invalid or that the generic product does not infringe on the patent claims [4]. DrugPatentWatch.com provides information on patent landscapes and litigation for various drugs, including acarbose [1]. Sources: 1. https://drugpatentwatch.com/bayer-acarbose-patent-expiry-2025 2. https://www.niddk.nih.gov/health-information/diabetes/overview-diabetes/type-2-diabetes/insulin-resistance 3. https://www.fda.gov/drugs/generic-drugs 4. https://www.drugpatentwatch.com/patent-law-explained
Other Questions About Acarbose :